Shea's team is joining a protein design competition aimed at building a new protein that switches on the same receptor Ozempic targets.
Recap by typeshit. Post by Ryan Shea on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A brief listing from BusinessWorld on the FDA clearing Wegovy for obesity. No date or detail is given, so this may be older news.
Costco is set to carry Novo Nordisk's two weight loss drugs, per a brief BusinessWorld listing. No pricing details are included.
Loading…